Partners / ADNKRONOS
-
November 4, 2026
Drugs: Prix Galien Italy to Italfarmaco for therapy in rare disease (2)
(Adnkronos Health) – “The fruit of Italian research, givinostat – reads the award’s motivation – represents a therapeutic innovation in Duchenne muscular dystrophy because it introduces a different mechanism of action, independent of the specific genetic mutation, with potential applicability to a broad population of eligible patients according to authorized indications. In association with corticosteroids, it has been shown to slow the progression of the disease and contribute to the more prolonged maintenance of motor function and autonomy, addressing a significant therapeutic need in the field of rare diseases, with a significant impact on the quality of life of patients and their families.” Duchenne muscular dystrophy is a rare genetic […]
-
November 4, 2026
Prix Galien Italy to Italfarmaco for therapy in rare disease
Rome, Nov 4. (Adnkronos Health) – Givinostat, a molecule that “has been shown in clinical studies to slow down the progression of Duchenne muscular dystrophy” thanks to a new mechanism of action, wins the Prix Galien Italy in the ‘Rare Diseases’ category. The drug – a note informs – represents a story of Italian scientific excellence and is the result of Italfarmaco’s research and development. The award ceremony took place yesterday in Turin. “The victory of the Prix Galien rewards not only an innovative molecule like givinostat, but also an entrepreneurial and scientific history built over time through constant investments in research and development – explains Francesco Di Marco, Group […]
-
November 4, 2026
Worker dies at Fincantieri in Marghera, possibly poisoned by chemical substance
Venice, 04 Nov. – (Adnkronos) – A 34-year-old worker lost his life this morning at Fincantieri in Marghera (Venice) while working inside a ship under construction. The man was reportedly overcome by an illness caused by a substance that may have poisoned him. A Fincantieri rescuer who had rushed to his aid also fell ill with the same symptoms and was immediately assisted by Suem 118. On site, in addition to Suem 118, were also the NBCR unit of the fire brigade and Spisal inspectors from the Venetian health authority to ascertain the causes and circumstances of the death. As a precautionary measure, the area has been evacuated. Environmental air […]
-
November 4, 2026
Senate President La Russa tomorrow at Adnkronos for AdnTalks, live from 3:20 PM
Rome, Nov 4. (Adnkronos) – The President of the Senate, Ignazio La Russa, will be tomorrow, November 5, at the Palazzo dell’Informazione in Piazza Mastai in Rome, for a visit to the Adnkronos newsroom. At 3:20 PM, he will be a live guest on ‘AdnTalks’, the format on the agency’s website and YouTube channel. He will be interviewed by director Davide Desario.
-
November 4, 2026
Leclerc, daughter Bianca is born: the announcement on social media
(Adnkronos) – Charles Leclerc has become a father. Today, Wednesday, November 4, the Ferrari driver announced the birth of his daughter Bianca, posting a photo of her feet, complete with a pink outfit, on his Instagram profile: “Bianca. 3.11.26”, Leclerc simply wrote, adding a white heart to the caption. To not miss the birth of his firstborn and to be with his wife Alexandra Saint Mieux, whom he married in recent months, Leclerc left Sao Paulo to temporarily return to Monte Carlo. Indeed, on Sunday, November 8, the Brazilian Grand Prix is scheduled at the Interlagos circuit, the first event of the World Championship after the triumph of Andrea Kimi […]
-
November 4, 2026
Research: Gilead awards 62 projects with over 1.2 million euros (2)
(Adnkronos Health) – The Gilead Calls – the note details – have established themselves over these fifteen years “as a virtuous example of public-private collaboration capable of generating value and innovation at scientific, organizational, and assistance levels.” The milestone of the 15th edition represented an opportunity, based on the experience of the Calls, “to promote a broader reflection on innovation in healthcare and the necessary conditions to transform it into concrete, widespread, and sustainable benefits for the country.” The topic was at the center of a round table that compared different perspectives: infectious disease specialist Massimo Andreoni, Davide Petruzzelli, president of La Lampada di Aladino Ets and vice-president of Favo; […]
-
November 4, 2026
Gilead awards 62 projects with over 1.2 million euros
Rome, Nov 4. (Adnkronos Health) – 62 projects have been awarded in the 15th edition of the Gilead Calls which, over the next twelve months – thanks to support of over 1.2 million euros – will contribute to improving scientific knowledge, prevention, diagnosis, and assistance in the areas of infectious, hepatic, oncological, and onco-hematological diseases. The winning projects, announced today in Rome during the ‘Generate Innovation. Create Health’ meeting – a note informs – include 29 initiatives in the medical-scientific field supported by the Fellowship Program and 33 promoted by Patient Associations and Third Sector Entities through the Community Award Program. With this edition, the projects supported by the two […]
-
November 4, 2026
Da Silva (Gilead): “Over 18 million invested in 15 years to bring innovation in health”
Rome, 4 Nov. (Adnkronos Health) – ‘The Gilead Calls represent a virtuous example of public-private collaboration, fundamental in our country to advance innovation in health. We have created a hub to support projects by researchers, patient associations, clinicians, and Third Sector entities. In 15 years, we have supported approximately 800 projects, with investments exceeding 18 million euros, involving over 5,000 patients and caregivers. But the most important result is the concrete impact on people’s lives.” This was stated by Frederico da Silva, vice president & general manager of Gilead Sciences Italy, at the event for the presentation and awarding of the winners of the 15th edition of the Gilead Calls, […]
-
November 4, 2026
Girelli (Pd): “Prevention is an investment, not an expense, the NHS risks not holding up”
Rome, Nov 4. (Adnkronos Health) – “Investing in prevention and risk reduction is a necessity: without it, the National Health Service will hardly be able to cope. However, a change of pace is needed, because we are still too slow in transforming innovation into daily practice. Budget constraints, bureaucracy, and organizational difficulties continue to slow down this process.” This was stated by Gian Antonio Girelli (Pd), a member of the XII Social Affairs Committee of the Chamber, at the presentation and award ceremony for the winners of the 15th edition of the Gilead Calls, in Rome. “Science and research offer us incredible opportunities, but often there are not enough resources […]
-
November 4, 2026
Andreoni: “Italy in suffering, investments too low compared to Europe”
Rome, 4 Nov. (Adnkronos Health) – “Italian research is in great suffering. Investments are too scarce even compared to other European countries: in Italy, only 1.37% of GDP is allocated to research, against a European average of 2.1%. In this scenario, calls for proposals like those from Gilead represent an important example of collaboration between independent public and private research, a synergy that can help keep Italy at the forefront of international research.” This was stated by Massimo Andreoni, emeritus professor of Infectious Diseases at Tor Vergata University in Rome, member of the Superior Health Council and president of the Fellowship Program Judging Committee, speaking at the ‘Generating Innovation. Creating […]